NEU 2.85% $20.13 neuren pharmaceuticals limited

Ann: 2021 Results - a transformational year for Neuren, page-75

  1. 5,888 Posts.
    lightbulb Created with Sketch. 17531
    Acadia released its Annual Report last week.

    As at the end of last quarter, Acadia had paid A$175m to external providers for trofinetide development.

    NDA preparation and submission costs are still to come and if and when trofinetide comes to market, Phase 4 post-marketing costs will kick in.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.13
Change
-0.590(2.85%)
Mkt cap ! $2.570B
Open High Low Value Volume
$20.41 $20.45 $20.02 $1.143M 56.71K

Buyers (Bids)

No. Vol. Price($)
1 125 $20.12
 

Sellers (Offers)

Price($) Vol. No.
$20.14 58 2
View Market Depth
Last trade - 11.14am 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.